Anti-Amyloid Infusion Therapy for Early Alzheimer's

Anti-amyloid infusion therapy may help slow the progression of early Alzheimer's disease. At Henry Ford Health, you can find comprehensive evaluations, advanced diagnostic testing and ongoing support throughout your treatment journey at one of the few health systems in Michigan that provide this care.

Patient sitting with an IV in their arm to undergo anti-amyloid infusion therapy for early Alzheimer's at Henry Ford Health.

Is Anti-Amyloid Therapy Right for You?

Ask your primary care provider for a neurology referral to get started.
Already have a referral for neurology?
Request a Consult

Here you'll learn about anti-amyloid infusion therapies offered at Henry Ford Health for patients with early-stage Alzheimer's disease and mild cognitive impairment, if you qualify, the testing required prior to beginning treatment, what to expect and more.

Why choose Henry Ford Health for anti-amyloid infusion therapy?

An Alzheimer's diagnosis can feel overwhelming. Our team is here to help you understand your options and provide support every step of the way. From evaluation and testing through treatment and long-term follow-up, we coordinate your care so you can focus on what matters most.

More about what we provide:

  • Comprehensive care from memory specialists experienced in diagnosing and treating Alzheimer's disease
  • Continuity of care with the same team throughout your treatment journey
  • A multidisciplinary team that includes physicians, nurse navigators, imaging specialists and social workers
  • Advanced diagnostic testing to determine whether you may benefit from infusion therapy
  • Specialized MRI protocols designed to monitor for amyloid-related imaging abnormalities (ARIA)
  • Specially trained radiologists to evaluate brain imaging for ARIA
  • Ongoing monitoring and cognitive assessments throughout treatment
  • Convenient infusion locations throughout southeast Michigan

Our experts work closely with you and your caregivers before, during and after treatment to help ensure you receive safe, personalized care.

What you should know about anti-amyloid infusion therapy

Anti-amyloid infusion therapies are designed for people in the early stages of Alzheimer's disease and mild cognitive impairment.

Learn more about your treatment options, eligibility requirements, what to expect and more below.

  • What anti-amyloid infusion therapies do we offer?

    Henry Ford Health offers two FDA-approved anti-amyloid infusion therapies for eligible patients with early Alzheimer's disease:

    Leqembi® (lecanemab)

    • Administered through an IV infusion approximately every two weeks
    • Treatment is typically continued over approximately 18 months

    Find more information about Leqembi® from our patient treatment guide here.

    Kisunla® (donanemab)

    • Administered through an IV infusion once every four weeks
    • Treatment generally lasts about 18 months, although some patients may complete treatment earlier depending on imaging results

    Find more information about Kisunla® from our patient treatment guide here.

    Both therapies:

    • Target harmful amyloid proteins in the brain
    • Help remove existing amyloid protein buildup
    • Are intended to slow progression of Alzheimer's disease
    • Are not cures for Alzheimer's disease

    The best treatment option depends on several factors, including medical history, test results, treatment goals and risk factors.

  • Who is anti-amyloid infusion therapy for?

    Anti-amyloid infusion therapy may be an option if you:

    • Have been diagnosed with mild cognitive impairment (MCI) due to Alzheimer's disease
    • Have mild Alzheimer's dementia
    • Meet specific treatment criteria determined through a neurological evaluation and testing process
    • The first step is a comprehensive evaluation with a neurology specialist.
    • To begin the process, patients typically need:
    • A referral to Neurology
    • Documentation of memory or cognitive changes
    • A complete cognitive evaluation

    Our team will review your medical history and testing results to determine whether infusion therapy may be appropriate for you.

  • What testing is needed before starting treatment?

    Several tests are required before treatment can begin. These tests help confirm the diagnosis, determine eligibility and establish a baseline for monitoring during therapy. 

    Cognitive and functional testing

    During your clinic visit, your care team will perform assessments that evaluate memory, thinking skills and daily functioning. These tests help determine whether treatment may be beneficial. 

    Confirmatory Alzheimer's testing

    You will need testing that confirms the presence of amyloid associated with Alzheimer's disease. This may include:

    • An amyloid PET scan
    • Cerebrospinal fluid (CSF) testing through a lumbar puncture 

    ApoE4 genetic testing

    ApoE4 is a gene associated with Alzheimer's disease and may increase the risk of a treatment-related side effect called amyloid-related imaging abnormalities (ARIA).

    This test is performed through a simple blood draw. Results help guide treatment discussions and monitoring plans.

    Baseline brain MRI

    You will need a brain MRI before your first infusion. This scan provides a baseline and helps your care team safely monitor treatment. Additional MRIs will be completed throughout therapy.

  • How does anti-amyloid infusion therapy work?

    Alzheimer's disease is a progressive brain condition that may be linked to the buildup of amyloid protein in the brain.

    Anti-amyloid therapies work by:

    • Targeting harmful amyloid proteins
    • Helping remove existing amyloid buildup from the brain

    Treatment is delivered through an intravenous (IV) infusion in a monitored infusion center. Throughout treatment, your care team will monitor your progress and perform periodic testing and imaging.

  • What is the treatment schedule?

    Treatment schedules vary depending on the medication prescribed.

    Leqembi®

    • Infusions occur every two weeks
    • Each infusion lasts about one hour
    • Treatment generally continues for 18 months
    • Additional MRI scans are completed during the first several months of treatment to monitor for amyloid-related imaging abnormalities (ARIA)

    Kisunla®

    • Infusions occur every four weeks
    • Each infusion lasts about 30 minutes
    • Treatment generally lasts about 18 months
    • Doses are gradually increased during the first several treatments
    • Additional MRI scans are completed during the first several months of treatment to monitor for ARIA 

    For both therapies, a caregiver should accompany you to infusion appointments. 

    After treatment begins, patients continue regular follow-up appointments and cognitive assessments approximately every six months.

  • What are the potential side effects or risks?

    Like all medications, anti-amyloid therapies can cause side effects and reactions. Most patients tolerate treatment well, but careful monitoring is important. 

    Amyloid-related imaging abnormalities (ARIA)

    ARIA is the most closely monitored side effect of treatment. It may involve temporary swelling or small areas of bleeding in the brain. Many patients have no symptoms, but possible symptoms include:

    • Headaches
    • Confusion
    • Dizziness
    • Nausea
    • Vision changes
    • Difficulty speaking or understanding speech
    • Weakness
    • Seizures 

    Infusion-related reactions

    Some patients may experience:

    • Nausea
    • Vomiting
    • Changes in blood pressure
    • Joint aches
    • Fatigue
    • Headaches

    Allergic reactions

    Although uncommon, serious allergic reactions can occur. Symptoms may include:

    • Hives or itching
    • Difficulty breathing
    • Throat swelling or tightness
    • Coughing 

    Your care team will review potential risks and warning signs before treatment begins.

  • What Henry Ford Health locations offer anti-amyloid infusion therapy?

    Find care at these locations:

    • Henry Ford Hospital (Detroit)
    • Henry Ford Macomb Hospital Rapid Infusion Center (Clinton Township)
    • Henry Ford Medical Center - Columbus (Novi)
    • Henry Ford Medical Center - Taylor
Show Me
View All Blog Posts

Cookie Consent

We use cookies to improve your website experience. By using this site, you agree to our Terms of Use. Read our Internet Privacy Statement  to learn what information we collect and how we use it.

Accept All
Dismiss